Casi Pharmaceuticals Inc Expected To Post A Loss Of 64 Cents A Share: Earnings Preview

CASI Pharmaceuticals

08/08/2022 19:33

* CASI Pharmaceuticals Inc  CASI.OQ   CASI.O  is expected
to show
a rise in quarterly revenue when it reports  results on August
12. 
    * The Rockville Maryland-based  company is expected to
report  a
10.0% increase in revenue to $7.875 million from $7.16 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for CASI
Pharmaceuticals Inc
is for a loss of 64 cents per share. For the same quarter last
year, the company reported a loss of 50 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $30​, above​ its last closing price
of $2.50. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -1.02       -0.87      -0.60     Beat    30.8
 Dec. 31 2022              -0.57      -0.40     Beat    29.4
 Sep. 30 2021  -0.55       -0.55      -0.70     Missed  -27.3​
 Jun. 30 2021  -0.76       -0.72      -0.50     Beat    31
 ​​Mar.        -0.61       -0.60      -1.10     Missed  -83.3
 31 2021                                                
 Dec. 31 2020              -0.70      -1.20     Missed  -71.4​
 Sep. 30 2020  -0.55       -0.55      -1.40     Missed  -154.5
 Jun. 30 2020  -0.80       -0.80      -0.70     Beat    12.5
 This summary was machine generated August 8 at 18:32 GMT.  All
figures in US dollars  unless otherwise stated